Literature DB >> 9690954

Effect of food and gender on the pharmacokinetics of tucaresol in healthy volunteers.

R W Peck1, R Wootton, R Wiggs, G Layton, J Posner.   

Abstract

AIMS: The potential effects of food and gender on the pharmacokinetics of tucaresol were investigated in healthy volunteers.
METHODS: Ten males (mean weight 76.5 kg, age 27-42 years) and eight females (mean weight 58.9 kg, age 18-44 years) received a single oral dose of 200 mg tucaresol on two occasions in random order. On one occasion, tucaresol was given after an overnight fast and on the other, immediately after ingestion of a standard breakfast.
RESULTS: There were no significant differences in standard pharmacokinetic parameters between the two occasions but the rate of tucaresol absorption was faster after food intake. Female subjects had higher Cmax (ratio 1.25 with 95% CI 1.10-1.44) and AUC (ratio 1.25 with 95% CI 1.05-1.49) values than males but the differences were due to the higher body weights of the males; weight-adjusted apparent total clearance values (CL/F) were not different between genders (ratio 1.03 with 95% CI 0.87-1.21).
CONCLUSIONS: Food intake and gender have no significant effect on the exposure to orally administered tucaresol.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9690954      PMCID: PMC1873973          DOI: 10.1046/j.1365-2125.1998.00047.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  5 in total

1.  The use of non-parametric methods in the statistical analysis of the two-period change-over design.

Authors:  G G Koch
Journal:  Biometrics       Date:  1972-06       Impact factor: 2.571

2.  Tucaresol increases oxygen affinity and reduces haemolysis in subjects with sickle cell anaemia.

Authors:  R Arya; P E Rolan; R Wootton; J Posner; A J Bellingham
Journal:  Br J Haematol       Date:  1996-06       Impact factor: 6.998

3.  Pharmacokinetics and pharmacodynamics of tucaresol, an antisickling agent, in healthy volunteers.

Authors:  P E Rolan; A J Mercer; R Wootton; J Posner
Journal:  Br J Clin Pharmacol       Date:  1995-04       Impact factor: 4.335

4.  The pharmacokinetics, tolerability and pharmacodynamics of tucaresol (589C80; 4[2-formyl-3-hydroxyphenoxymethyl] benzoic acid), a potential anti-sickling agent, following oral administration to healthy subjects.

Authors:  P E Rolan; J E Parker; S J Gray; B C Weatherley; J Ingram; W Leavens; R Wootton; J Posner
Journal:  Br J Clin Pharmacol       Date:  1993-04       Impact factor: 4.335

5.  Therapeutic potentiation of the immune system by costimulatory Schiff-base-forming drugs.

Authors:  J Rhodes; H Chen; S R Hall; J E Beesley; D C Jenkins; P Collins; B Zheng
Journal:  Nature       Date:  1995-09-07       Impact factor: 49.962

  5 in total
  1 in total

Review 1.  Effects of food on clinical pharmacokinetics.

Authors:  B N Singh
Journal:  Clin Pharmacokinet       Date:  1999-09       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.